BrightPath Biotherapeutics Co (TSE:4594) Cyclically Adjusted Book per Share: 円80.06 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4594 BrightPath Biotherapeutics Co Ltd TSE:4594
34 GF Score
Price 円53.00
! 3 Warning Signs
View Full Analysis

What is BrightPath Biotherapeutics Co Cyclically Adjusted Book per Share?

BrightPath Biotherapeutics Co TSE:4594 34 Cyclically Adjusted Book per Share is 円80.06 as of Mar. 2026. GuruFocus rates TSE:4594 with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BrightPath Biotherapeutics Co's adjusted book value per share for the three months ended in Mar. 2026 was 円17.053. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円80.06 for the trailing ten years ended in Mar. 2026.

During the past 12 months, BrightPath Biotherapeutics Co's average Cyclically Adjusted Book Growth Rate was -4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-26), BrightPath Biotherapeutics Co's current stock price is 円53.00. BrightPath Biotherapeutics Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was 円80.06. BrightPath Biotherapeutics Co's Cyclically Adjusted PB Ratio of today is 0.66.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of BrightPath Biotherapeutics Co was 0.66. The lowest was 0.00. And the median was 0.00.


BrightPath Biotherapeutics Co  (TSE:4594) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BrightPath Biotherapeutics Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=53.00/80.06
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of BrightPath Biotherapeutics Co was 0.66. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BrightPath Biotherapeutics Co Cyclically Adjusted Book per Share Related Terms


BrightPath Biotherapeutics Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for BrightPath Biotherapeutics Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BrightPath Biotherapeutics Co Cyclically Adjusted Book per Share Chart

BrightPath Biotherapeutics Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 83.96 80.06

BrightPath Biotherapeutics Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.52 81.99 82.49 80.06 0.00

TSE:4594 vs VRTX, REGN, RVMD: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, BrightPath Biotherapeutics Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BrightPath Biotherapeutics Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BrightPath Biotherapeutics Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BrightPath Biotherapeutics Co's Cyclically Adjusted PB Ratio falls into.


TSE:4594
34GF Score
BrightPath Biotherapeutics Co Ltd TSE:4594
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BrightPath Biotherapeutics Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BrightPath Biotherapeutics Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=17.053/112.7000*112.7000
=17.053

Current CPI (Mar. 2026) = 112.7000.

BrightPath Biotherapeutics Co Quarterly Data

Book Value per Share CPI Adj_Book
201603 85.534 97.900 98.465
201606 113.076 98.100 129.905
201609 115.169 98.000 132.444
201612 122.965 98.400 140.835
201703 139.714 98.100 160.507
201706 132.892 98.500 152.050
201709 121.588 98.800 138.694
201712 112.549 99.400 127.608
201803 166.142 99.200 188.752
201806 152.349 99.200 173.082
201809 141.913 99.900 160.096
201812 131.074 99.700 148.165
201903 121.352 99.700 137.175
201906 111.165 99.800 125.534
201909 101.157 100.100 113.890
201912 89.196 100.500 100.024
202003 76.845 100.300 86.345
202006 83.100 99.900 93.747
202009 84.540 99.900 95.372
202012 76.185 99.300 86.466
202103 69.614 99.900 78.534
202106 61.830 99.500 70.033
202109 58.012 100.100 65.314
202112 51.256 100.100 57.708
202203 45.816 101.100 51.073
202206 37.400 101.800 41.405
202209 34.070 103.100 37.242
202212 29.059 104.100 31.460
202303 24.925 104.400 26.907
202306 20.222 105.200 21.664
202309 16.117 106.200 17.103
202312 11.918 106.800 12.576
202403 13.839 107.200 14.549
202406 9.440 108.200 9.833
202409 14.728 108.900 15.242
202503 10.222 111.100 10.369
202506 11.255 111.700 11.356
202509 13.704 112.000 13.790
202512 9.976 113.000 9.950
202603 17.053 112.700 17.053

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円80.06 mean?
BrightPath Biotherapeutics Co (TSE:4594) has a Cyclically Adjusted Book per Share of 円80.06 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BrightPath Biotherapeutics Co and its competitors.
Is BrightPath Biotherapeutics Co's Cyclically Adjusted Book per Share too high?
BrightPath Biotherapeutics Co's current Cyclically Adjusted Book per Share is 円80.06. Overall, BrightPath Biotherapeutics Co has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does BrightPath Biotherapeutics Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
BrightPath Biotherapeutics Co's Cyclically Adjusted Book per Share of 円80.06 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BrightPath Biotherapeutics Co and its competitors. BrightPath Biotherapeutics Co's current Cyclically Adjusted Book per Share is 円80.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BrightPath Biotherapeutics Co stock overvalued right now?
BrightPath Biotherapeutics Co (TSE:4594) has a current Cyclically Adjusted Book per Share of 円80.06. The current Cyclically Adjusted Book per Share is 円80.06. BrightPath Biotherapeutics Co's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For BrightPath Biotherapeutics Co (TSE:4594), the current Cyclically Adjusted Book per Share is 円80.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BrightPath Biotherapeutics Co Business Description

Address 2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
34GF Score

Get the complete analysis for TSE:4594

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円53.00
Price